日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A pan-cancer atlas of therapeutic T cell targets.

泛癌治疗性T细胞靶点图谱

Li Guangyuan, Guzmán-Bringas Omar U, Sharma Aman, Dellacherie Maxence, Sekhri Palak, Yamin Rachel, Stepec Dejan, Burq Maximilien, Clotea Ioana, Tardio Ethan, Natarajan Aswin, Harpaz Zachary, Liu Xinya, Requena David, Taylor Darren, Ueberheide Beatrix M, Krogsgaard Michelle, Cruz C Russell Y, Cimermancic Peter, Yarmarkovich Mark

Cellular and Humoral Immunity to SARS-CoV-2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease-Modifying Therapies: A Multi-Ethnic Observational Study.

接受奥瑞珠单抗和其他疾病修饰疗法治疗的多发性硬化症患者的 SARS-CoV-2 感染的细胞和体液免疫:一项多民族观察性研究

Kister Ilya, Patskovsky Yury, Curtin Ryan, Pei Jinglan, Perdomo Katherine, Rimler Zoe, Voloshyna Iryna, Samanovic Marie I, Cornelius Amber R, Velmurugu Yogambigai, Nyovanie Samantha, Kim Joseph J, Tardio Ethan, Bacon Tamar E, Zhovtis Ryerson Lana, Raut Pranil, Pedotti Rosetta, Hawker Kathleen, Raposo Catarina, Priest Jessica, Cabatingan Mark, Winger Ryan C, Mulligan Mark J, Krogsgaard Michelle, Silverman Gregg J

Hybrid and vaccine-induced immunity against SAR-CoV-2 in MS patients on different disease-modifying therapies.

接受不同疾病修饰疗法的 MS 患者对 SARS-CoV-2 的混合免疫和疫苗诱导免疫

Kister Ilya, Curtin Ryan, Pei Jinglan, Perdomo Katherine, Bacon Tamar E, Voloshyna Iryna, Kim Joseph, Tardio Ethan, Velmurugu Yogambigai, Nyovanie Samantha, Valeria Calderon Andrea, Dibba Fatoumatta, Stanzin Igda, Samanovic Marie I, Raut Pranil, Raposo Catarina, Priest Jessica, Cabatingan Mark, Winger Ryan C, Mulligan Mark J, Patskovsky Yury, Silverman Gregg J, Krogsgaard Michelle